1-20 of 136
Hervé Ghesquieres
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Characteristics and Outcomes of Aggressive Transformation in Splenic Marginal Zone Lymphoma: An International Study of 111 Patients

Ahmed Ludvigsen Al-Mashhadi, Mikkel Runason Simonsen, Elizabeth Smyth, Rose-Marie Amini, Bente Arboe, James R. Cerhan, Iman Chanchiri, Chan Y. Cheah, Jonathan Day, Toby A. Eyre, Anne Ortved Gang, Hervé Ghesquieres, Thomas M. Habermann, Eliza A. Hawkes, Steven R. Hwang, Ruxandra Irimia, Jennifer B Jørgensen, Arushi Khurana, Claire Maquet, Ng Layshe, Stephen S. Opat, Martin Bjerregård Pedersen, Christian Bjørn Poulsen, Alexandros Rampotas, Andreea Sima, Karin Ekstroem Smedby, Knut Smeland, Gita Thanarajasingam, Judith Trotman, Katharine Xing, Simon Østergaard, Diego Villa, Tarec Christoffer El-Galaly
Journal: Blood
Blood (2024) 144 (Supplement 1): 3019.
https://doi.org/10.1182/blood-2024-204328
Published: 2024
Journal Articles

Durability of Complete Responses in Patients from the ECHELON-3 Study

Christopher Yasenchak, Nancy L. Bartlett, Jeong-A Kim, Uwe Hahn, Craig A. Portell, Francesco Zaja, Thorsten Zenz, Cecily Forsyth, Jin Seok Kim, Seok-Goo Cho, Jae-Yong Kwak, Hao-Yuan Wang, Herve Ghesquieres, Grzegorz S. Nowakowski, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Frank Stenner
Journal: Blood
Blood (2024) 144 (Supplement 1): 3101.
https://doi.org/10.1182/blood-2024-194158
Published: 2024
Journal Articles

Hematopoietic Stem Cell Transplantation for Marginal Zone Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Yasmina I.M. Serroukh, Mathilde Fekom, Irma Khvedelidze, Ben Carpenter, Herve Ghesquieres, Ludovic Gabellier, Jacques-Olivier Bay, Didier Blaise, Maurizio Musso, Patrice Chevallier, Edouard Forcade, Anne Huynh, Andy Peniket, Marek Trněný, Catherine Flynn, Shankara Paneesha, Andrew Clark, Charalampia Kyriakou, Anna Ossami Saidy, Bertram Glass, Luca Castagna, Silvia Montoto, Ali Bazarbachi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3027.
https://doi.org/10.1182/blood-2024-194632
Published: 2024
Journal Articles

Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up

Loretta Nastoupil, Saurabh Dahiya, Maria Lia Palomba, Alejandro Martín García-Sancho, Juan Luis Reguera, John Kuruvilla, Ulrich Jaeger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad S. Kahl, Herve Ghesquieres, Kirit Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S. Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Alan P Skarbnik, Manali Kamdar, Reem Karmali, Andreas Viardot, Thalia Farazi, Grace Shih Hui Kao, Min Vedal, Rina Nishii, Jessica Papuga, Jinender Kumar, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 4387.
https://doi.org/10.1182/blood-2024-198509
Published: 2024
Journal Articles

Outcomes of Patients with Hodgkin Lymphoma Receiving Brentuximab Vedotin (BV) As Maintenance Therapy after ASCT According to Previous Exposure to BV. a Retrospective Analysis of the EBMT Lymphoma Working Party in Collaboration with Geltamo, FIL, Lysarc, and Turkish Lymphoma Group

Maria Carmen Martinez Munoz, Irma Khvedelidze, Mathilde Fekom, Benedicte Deau Fischer, Amira Marouf, Herve Ghesquieres, Luc-Matthieu Fornecker, Francesco Merli, Piero Maria Stefani, Fulvio Massaro, Barbara Botto, A. Burhan Ferhanoglu, Olga Meltem Akay, Murat Ozbalak, Manuel Espeso De Haro, Samuel Romero, Jaques-Emmanuel Galimard, Bertram Glass, Ali Bazarbachi, Anna Sureda Balari
Journal: Blood
Blood (2024) 144 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2024-205007
Published: 2024
Journal Articles

Distinct Molecular Aberrations of Classic Hodgkin Lymphoma in Older Adults Identified By Comprehensive Genomic Profiling

Cedric Rossi, Jan Boegeholz, Jordan S Goldstein, Shuyu Shi, Shengqin Su, Benoit Tessoulin, Stefan K. Alig, Andrea Garofalo, Mohammad Shahrokh Esfahani, Joseph G. Schroers-Martin, Chih Long Liu, Mari Olsen, Xiaoman Kang, Feng Tian, David Kurtz, Takeshi Sugio, Troy Noordenbos, Marc Andre, Luc-Matthieu Fornecker, Edith Julia, Alexandra Traverse-Glehen, Olivier Casasnovas, Michael S. Binkley, Maximilian Diehn, Herve Ghesquieres, Ash A. Alizadeh
Journal: Blood
Blood (2024) 144 (Supplement 1): 853.
https://doi.org/10.1182/blood-2024-201644
Published: 2024
Journal Articles

Outcomes of Primary Mediastinal B-Cell Lymphoma Patients Treated with a PET-Guided Strategy in the Randomized Phase 3 Gained Study Conducted By Lysa

Vincent Camus, Thierry Jo Molina, Fabienne Desmots-Loyer, Amine Moslemi, Philippe Ruminy, Steven Le Gouill, Herve Ghesquieres, Lucie Oberic, Franck Morschhauser, Hervé Tilly, Vincent Ribrag, Roch Houot, Catherine Thieblemont, Herve Maisonneuve, Fabien Claves, Krimo Bouabdallah, Corinne Haioun, Gandhi Damaj, Luc-Matthieu Fornecker, Robin Noel, Pierre Feugier, David Sibon, Guillaume Cartron, Christophe Bonnet, Marc André, Françoise Kraeber-Bodéré, Caroline Milin, Jean-Philippe Jais, Josette Briere, Olivier Casasnovas, Salim Kanoun, Emmanuel Itti, Paul Blanc-Durand, Mad-Hélénie Elsensohn, Loic Chartier, Fabrice Jardin, Thierry Fest
Journal: Blood
Blood (2024) 144 (Supplement 1): 575.
https://doi.org/10.1182/blood-2024-202446
Published: 2024
Journal Articles

Englumafusp Alfa (CD19-4-1BBL) Combined with Glofitamab Is Safe and Efficacious in Patients with r/r B-NHL: Extended Follow up Analysis of the Dose-Escalation Part of Phase 1 Trial BP41072

Martin Hutchings, Michael J. Dickinson, Giuseppe Gritti, Carmelo Carlo-Stella, William Townsend, Francesc Bosch, Nancy L. Bartlett, Guillaume Cartron, Herve Ghesquieres, Roch Houot, Harriet S. Walter, Fritz Offner, Natalie Dimier, Candice Jamois, Lance Smith, Sylvia Herter, Denis Sahin, Abiraj Keelara, Koorosh Korfi, Jeremy Gallien, Marie-Helene Wasmer, Heather Hinton, Matt Whayman, Isabel Prieto, Georgios Kazantzidis, Katharina Lechner, Franck Morschhauser
Journal: Blood
Blood (2024) 144 (Supplement 1): 990.
https://doi.org/10.1182/blood-2024-200096
Published: 2024
Journal Articles

Senior-IPI: An Easily Applicable and Meaningful Prognostic Index for First-Line LBCL Patients Older Than 80 Years Treated with Age-Adapted Immunochemotherapy

Sydney Dubois, Fanny Cherblanc, Aurelien Belot, Lucie Oberic, Herve Ghesquieres, Corinne Haioun, Hervé Tilly, Jean-Philippe Jais, Fabrice Jardin
Journal: Blood
Blood (2024) 144 (Supplement 1): 649.
https://doi.org/10.1182/blood-2024-203926
Published: 2024
Journal Articles

Impact of Health Literacy in Hematology Outpatients Receiving Oral Anticancer Drugs and Followed By the Oncoral Multidisciplinary City-Hospital Educational Follow-up

Chloé Herledan, Florence Ranchon, Marie Preau, Agathe Komaroff, Anissa Guillemin, Magali Maire, Anne-Gaëlle Ruiz-Caffin, Lionel Karlin, Emmanuelle Ferrant, Gilles Salles, Hervé Ghesquieres, Catherine Rioufol
Journal: Blood
Blood (2024) 144 (Supplement 1): 3667.
https://doi.org/10.1182/blood-2024-207301
Published: 2024
Journal Articles

Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Uwe Hahn, Nancy L. Bartlett, Jeong-A Kim, Krimo Bouabdallah, Nicholas Forward, Tsai-Yun Chen, Vincent Camus, Ming-Chung Wang, Philippe Carassou, Enrico Derenzini, Hung Chang, Fritz Offner, Herve Ghesquieres, Grzegorz S. Nowakowski, Christopher Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Craig A. Portell
Journal: Blood
Blood (2024) 144 (Supplement 1): 4489.
https://doi.org/10.1182/blood-2024-200914
Published: 2024
Journal Articles

Outcomes in Older Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Nancy L. Bartlett, Jeong-A Kim, Uwe Hahn, Isabelle Fleury, Kamel Laribi, Juan Miguel Bergua Burgues, Craig A. Portell, Melina Boutin, Blanca Sanchez Gonzalez, Selay Lam, Sung Yong Oh, Judit Mészáros Joergensen, Young Rok Do, Herve Ghesquieres, Grzegorz S. Nowakowski, Christopher Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Vincent Ribrag
Journal: Blood
Blood (2024) 144 (Supplement 1): 4483.
https://doi.org/10.1182/blood-2024-200836
Published: 2024
Journal Articles

Allogeneic Stem-Cell Transplantation for Relapsed/Refractory ALK-Positive Anaplastic Large-Cell Lymphoma: A Study from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Thomas Grange, Jean-Philippe Jais, Flore Sicre de Fontbrune, Cristina Castilla-Llorente, Ambroise Marçais, Herve Ghesquieres, Raynier Devillier, Ibrahim Yakoub-Agha, Karin Bilger, François-Xavier Gros, Natacha Maillard, Anne Huynh, Jean-Baptiste Méar, Marie-Thérèse Rubio, Johan Maertens, Patrice Chevallier, Fanny Rialland Battisti, Sylvie François, Claude-Éric Bulabois, Alban Villate, Michael Loschi, Cécile Renard, Amandine Charbonnier, Bénédicte Bruno, Jacques-Olivier Bay, Christine Devalck, Jérome Cornillon, Xavier Poiré, Arthur Sterin, Ludovic Gabellier, Nicole Raus, Stéphanie Nguyen-Quoc, Charlotte Rigaud, David Sibon
Journal: Blood
Blood (2024) 144 (Supplement 1): 4946.
https://doi.org/10.1182/blood-2024-212055
Published: 2024
Journal Articles

3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma

Julie M. Vose, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Herve Ghesquieres, Wojciech Jurczak, Kim Linton, Catherine Thieblemont, Tycel J. Phillips, Won Seog Kim, Pegah Jafarinasabian, Barbara D'Angelo Månsson, David Soong, Andrew J. Steele, Zhu Li, Christian Eskelund, Martin Hutchings, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 4480.
https://doi.org/10.1182/blood-2024-198714
Published: 2024
Journal Articles

Outcomes of Patients Treated with Consolidative Brentuximab Vedotin after Transplant for Hodgkin Lymphoma at High Risk of Progression or Relapse: An Innovative Comparative Analysis Based on Propensity Score Weighting from Patients Included in 4 Lysa-Cohorts

Amira Marouf, Cedric Rossi, Tesla Murairi, Fanny Cherblanc, Loic Chartier, Hervé Ghesquieres, Bénédicte Deau Fischer
Journal: Blood
Blood (2024) 144 (Supplement 1): 4424.
https://doi.org/10.1182/blood-2024-209608
Published: 2024
Journal Articles

Outcome of Hematopoietic Stem Cell Transplantation for Follicular Lymphoma, a Benchmark Study from the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Yasmina I.M. Serroukh, Mathilde Fekom, Irma Khvedelidze, Ben Carpenter, Herve Ghesquieres, Ludovic Gabellier, Jacques-Olivier Bay, Didier Blaise, Maurizio Musso, Patrice Chevallier, Edouard Forcade, Anne Huynh, Andy Peniket, Marek Trněný, Catherine Flynn, Shankara Paneesha, Andrew Clark, Charalampia Kyriakou, Anna Ossami Saidy, Bertram Glass, Luca Castagna, Silvia Montoto, Ali Bazarbachi
Journal: Blood
Blood (2024) 144 (Supplement 1): 749.
https://doi.org/10.1182/blood-2024-194657
Published: 2024
Journal Articles

Myeloid Neoplasia after CD19 Directed CAR-T Cells : Cumulative Incidence, Risk Factors and Outcome

Nicolas Gazeau, David Beauvais, Rémi Tilmont, Micha Srour, Emmanuelle Ferrant, Violaine Safar, Gandhi Damaj, Nicolas Gower, Nicolas Duployez, Sarah Huet, Herve Ghesquieres, Emmanuel Bachy, Franck Morschhauser, Ibrahim Yakoub-Agha, Mael Heiblig, Pierre Sesques
Journal: Blood
Blood (2024) 144 (Supplement 1): 2079.
https://doi.org/10.1182/blood-2024-208851
Published: 2024
Journal Articles

PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Participants with Relapsed/Refractory Hematologic Malignancies

Tae Min Kim, Katharine L. Lewis, Juan Pablo Alderuccio, Hun Ju Lee, Enrico Derenzini, Pier Luigi Zinzani, Marco Ladetto, Elizabeth H. Phillips, Hervé Ghesquieres, François Lemonnier, Franck Morschhauser, Ana Sureda Balari, Antonia Rodriguez Izquierdo, Peter Borchmann, Matthew Weinstock, Jakub Svoboda, Emma Dean, Jelena Urosevic, Stefanie Meyer, Robert Chen, Richard Olsson, Kaitlyn Beyfuss, Graham P. Collins
Journal: Blood
Blood (2024) 144 (Supplement 1): 1674.2.
https://doi.org/10.1182/blood-2024-203060
Published: 2024
Journal Articles

Ultrasensitive Circulating Tumor DNA MRD Status Predicts Treatment Failure & Complements PET/CT throughout Treatment for Early and Advanced Stage Classic Hodgkin Lymphoma

Jan Boegeholz, Cedric Rossi, Jordan S Goldstein, Stefan K. Alig, Andrea Garofalo, Mohammad Shahrokh Esfahani, Joseph G. Schroers-Martin, Chih Long Liu, Mari Olsen, Xiaoman Kang, Feng Tian, David Kurtz, Marc Andre, Luc-Matthieu Fornecker, Olivier Casasnovas, Maximilian Diehn, Herve Ghesquieres, Ash A. Alizadeh
Journal: Blood
Blood (2024) 144 (Supplement 1): 565.
https://doi.org/10.1182/blood-2024-201877
Published: 2024
Journal Articles

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

Clinical Trials & Observations
Hervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, Salim Kanoun, Anne Claire Gac, Stéphanie Guidez, Mohamed Touati, Kamel Laribi, Franck Morschhauser, Christophe Bonnet, Agathe Waultier-Rascalou, Frédérique Orsini-Piocelle, Marc André, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Barbara Burroni, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, Olivier Casasnovas
Journal: Blood
Blood (2024) 143 (11): 983–995.
https://doi.org/10.1182/blood.2023021564
Published: 2024
Includes: Supplemental data